De novo human angiotensin-converting enzyme 2 decoy NL-CVX1 protects mice from severe disease...

SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 …

R Ameratunga, A Jordan, K Lehnert, E Leung… - Antiviral Research, 2024 - Elsevier
COVID-19 has caused calamitous health, economic and societal consequences. Although
several COVID-19 vaccines have received full authorization for use, global deployment has …
相关文章 所有 3 个版本

Soluble wild-type ACE2 molecules inhibit newer SARS-CoV-2 variants and are a potential antiviral strategy to mitigate disease severity in COVID-19

R Ameratunga, E Mears, E Leung… - Clinical and …, 2023 - academic.oup.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for
coronavirus disease of 2019 (COVID-19), has caused havoc around the world. While …
被引用次数：2 相关文章 所有 4 个版本